Article
Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Sept 2003
Martin Karine, Brie Anne, Saulnier Patrick, Perricaudet Michel, Yeh Patrice, Vigne Emmanuelle
Abstract excerpt
Targeting adenovirus encoding therapeutic genes to specific cell types has become a major goal in gene therapy. Coxsackievirus and adenovirus receptor (CAR) and alpha(V) integrins have been identified as the primary cell surface components that interact with adenovirus type 5 (Ad5)-based vectors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
